EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Clinical Efficacy and Preliminary Cost-Utility of Low-Frequency Repetitive Transcranial Magnetic Stimulation Versus Sham Stimulation for Neurogenic Overactive Bladder in Stroke Survivors: A Randomized Controlled Trial

Mohammed Usman Ali iD, Kenneth N K Fong, Georg S Kranz, Jingjing Li, Crystal Kwan, Priya Kannan

Neurorehabilitation and Neural Repair · 2026-08 · 40 (8) · 603-614

DOI: 10.1177/15459683261432087 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neurorehabilitation and Neural Repair, online erschienen am 29.04.2026. Verfasst von Mohammed Usman Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Transcranial Magnetic Stimulation, Stroke. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: hong kong polytechnic university.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurogenic overactive bladder (OAB) among survivors is burdensome. Low-frequency repetitive transcranial magnetic stimulation (rTMS) is a promising non-invasive intervention requiring comprehensive evaluation of its clinical and economic impact.

Objectives

To evaluate the efficacy, cost-utility, and stroke survivors’ experiences of rTMS for neurogenic OAB.

Methods

In this randomized, assessor-blinded, sham-controlled trial, 60 stroke survivors with neurogenic OAB received active rTMS (1200 pulses 80% resting motor threshold [RMT]) or sham (20% RMT) thrice weekly for 4 weeks at contralateral primary motor cortex. The OAB Symptom Score (OABSS), Incontinence Quality of Life (I-QOL), and Brief Resilience Scale (BRS)—were measured at baseline, week 4, and week 8. Repeated measures analysis of covariance evaluated effects. Cost-utility analysis used societal costs and quality-adjusted life years (QALYs). Focus groups involved 12 active-group participants.

Results

Active rTMS (n = 30; 60% male; mean age = 62.1 ± 9.5 years) significantly improved OABSS (mean difference [MD] = 1.81 points, 95% confidence interval [CI] [1.42-2.20], P < .001), I-QOL (MD = 17.48 points, 95% CI [14.18-20.79], P < .001), and BRS (MD = 0.25 points, 95% CI [0.09-0.41], P = .002), at weeks 4 and 8 compared to sham (n = 30; 47% male; mean age = 61.7 ± 8.3 years). Active rTMS was associated with lower societal costs (HK$1267.3 vs HK$1839.0) and higher QALYs (0.691 vs 0.571) than sham. Qualitative data indicated excellent tolerability, symptom relief, and acceptability.

Conclusions

Low-frequency rTMS is clinically effective, safe, acceptable, and potentially cost-saving for post-stroke neurogenic OAB. Larger trials with active comparators and extended follow-up are warranted. Trial Registration This trial was registered at http://ClinicalTrials.gov (reference number: NCT05557175) before the recruitment of the first participant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder, OveractiveTranscranial Magnetic StimulationStrokeHumansFemaleMaleMiddle AgedAgedCost-Benefit AnalysisTreatment OutcomeQuality of LifeSurvivors

Stichwörter der Autor:innen

cost-utilityneurogenic overactive bladderqualitative studyrepetitive transcranial magnetic stimulationstroke

Autor:innen und Institutionen

  • Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.
  • Research Centre for Assistive Technology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.
  • Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria.
  • Department of Applied Social Sciences, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.

ORCID-Profile: Mohammed Usman Ali

Förderung

  • hong kong polytechnic university

Zitieren

APA

Ali, M. U., Fong, K. N. K., Kranz, G. S., Li, J., Kwan, C., & Kannan, P. (2026). Clinical Efficacy and Preliminary Cost-Utility of Low-Frequency Repetitive Transcranial Magnetic Stimulation Versus Sham Stimulation for Neurogenic Overactive Bladder in Stroke Survivors: A Randomized Controlled Trial. Neurorehabilitation and Neural Repair, 40(8), 603-614. https://doi.org/10.1177/15459683261432087

Vancouver

Ali MU, Fong KNK, Kranz GS, Li J, Kwan C, Kannan P. Clinical Efficacy and Preliminary Cost-Utility of Low-Frequency Repetitive Transcranial Magnetic Stimulation Versus Sham Stimulation for Neurogenic Overactive Bladder in Stroke Survivors: A Randomized Controlled Trial. Neurorehabilitation and Neural Repair. 2026;40(8):603-614. doi:10.1177/15459683261432087

BibTeX
@article{Ali2026,
  author = {Ali, Mohammed Usman and Fong, Kenneth N K and Kranz, Georg S and Li, Jingjing and Kwan, Crystal and Kannan, Priya},
  title = {Clinical Efficacy and Preliminary Cost-Utility of Low-Frequency Repetitive Transcranial Magnetic Stimulation Versus Sham Stimulation for Neurogenic Overactive Bladder in Stroke Survivors: A Randomized Controlled Trial},
  journal = {Neurorehabilitation and Neural Repair},
  year = {2026},
  volume = {40},
  number = {8},
  pages = {603--614},
  doi = {10.1177/15459683261432087}
}
Kostenlos starten →